BETZ STEPHEN F. (Chief Scientific Officer) exercised options at CRINETICS PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 12/29/2025ACC: 0001628280-25-059009
Officer· Chief Scientific Officer
Since Oct 2021
0.00
Net shares
Net seller
$34.4K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
18K acquired · 18K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+18K
Price / share
$1.91
Trade value
$34.38K
% of position
18.1%
12/26/2025
99.71K→117.71K
Total
Net shares
+18K
Net value
$34.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/26/2025 | M · Option Exercise | +18K | $1.91 | $34.38K | 18.1% | 99.71K | 117.71K |
| Total | +18K | $34.38K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
18K shares
Shares
−18K
Strike price
1.91
Held after
90.51K
Exercisable
—
12/26/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock18K shares | 12/26/2025 | M · Option Exercise | −18K | 1.91 | — | 90.51K |